Shares of Theralase Technologies Inc. (CVE:TLT – Get Free Report) rose 10.2% during mid-day trading on Tuesday . The company traded as high as C$0.28 and last traded at C$0.27. Approximately 223,000 shares changed hands during mid-day trading, an increase of 115% from the average daily volume of 103,522 shares. The stock had previously closed at C$0.25.
Theralase Technologies Stock Up 14.3 %
The company has a market cap of C$68.75 million, a P/E ratio of -14.00 and a beta of 1.36. The company has a quick ratio of 3.40, a current ratio of 1.21 and a debt-to-equity ratio of 20.58. The company has a fifty day moving average of C$0.27 and a 200 day moving average of C$0.23.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Read More
- Five stocks we like better than Theralase Technologies
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Expert Stock Trading Psychology Tips
- What Does the Future Hold for Eli Lilly?
- How to Calculate Options Profits
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
